The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Sumeray Mark since 2013.
The trader's CIK number is 1527134.
At the time of the last reporting, Sumeray Mark was the Chief Medical Officer of Aegerion Pharmaceuticals, Inc.. (stock ticker symbol AEGR).
Also see all insider trading activities at Aegerion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | AEGR | 0 | $0 | 7,000 | $418,559 | 7,000 | $91,070 |
| 2013 | AEGR | 0 | $0 | 40,000 | $2,718,389 | 40,000 | $520,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-03-14 | AEGR | Option Ex | 2,000 | 13.01 | 26,020 |
| 2014-03-14 | AEGR | Sale | 2,000 | 50.99 | 101,986 |
| 2014-02-14 | AEGR | Option Ex | 2,000 | 13.01 | 26,020 |
| 2014-02-14 | AEGR | Sale | 2,000 | 63.83 | 127,660 |
| 2014-01-16 | AEGR | Sale | 2,000 | 59.05 | 118,098 |
| 2014-01-16 | AEGR | Option Ex | 2,000 | 13.01 | 26,020 |
| 2014-01-02 | AEGR | Option Ex | 1,000 | 13.01 | 13,010 |
| 2014-01-02 | AEGR | Sale | 1,000 | 70.81 | 70,815 |
| 2013-12-16 | AEGR | Option Ex | 2,000 | 13.01 | 26,020 |
| 2013-12-16 | AEGR | Sale | 2,000 | 66.80 | 133,608 |
| 2013-12-02 | AEGR | Option Ex | 3,000 | 13.01 | 39,030 |
| 2013-12-02 | AEGR | Sale | 3,000 | 70.71 | 212,138 |
| 2013-11-15 | AEGR | Option Ex | 2,000 | 13.01 | 26,020 |
| 2013-11-15 | AEGR | Sale | 2,000 | 76.15 | 152,302 |
| 2013-11-01 | AEGR | Option Ex | 3,500 | 13.01 | 45,535 |
| 2013-11-01 | AEGR | Sale | 3,500 | 83.56 | 292,474 |
| 2013-10-15 | AEGR | Option Ex | 2,000 | 13.01 | 26,020 |
| 2013-10-15 | AEGR | Sale | 2,000 | 80.33 | 160,658 |
| 2013-10-07 | AEGR | Option Ex | 3,500 | 13.01 | 45,535 |
| 2013-10-07 | AEGR | Sale | 3,500 | 93.47 | 327,141 |
| 2013-09-16 | AEGR | Option Ex | 2,000 | 13.01 | 26,020 |
| 2013-09-16 | AEGR | Sale | 2,000 | 90.29 | 180,580 |
| 2013-08-16 | AEGR | Option Ex | 2,000 | 13.01 | 26,020 |
| 2013-08-16 | AEGR | Sale | 2,000 | 88.97 | 177,938 |
| 2013-07-15 | AEGR | Sale | 2,000 | 78.61 | 157,220 |
| 2013-07-15 | AEGR | Option Ex | 2,000 | 13.01 | 26,020 |
| 2013-06-17 | AEGR | Option Ex | 6,000 | 13.01 | 78,060 |
| 2013-06-17 | AEGR | Sale | 6,000 | 65.86 | 395,130 |
| 2013-05-15 | AEGR | Option Ex | 6,000 | 13.01 | 78,060 |
| 2013-05-15 | AEGR | Sale | 6,000 | 47.32 | 283,932 |
| 2013-04-22 | AEGR | Option Ex | 6,000 | 13.01 | 78,060 |
| 2013-04-22 | AEGR | Sale | 6,000 | 40.88 | 245,268 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sumeray Mark (Chief Medical Officer of Aegerion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.